France bars Telegram founder Pavel Durov from visiting US for a business trip

Russian-born Durov is currently under judicial supervision in France, holed up in Paris' glitzy Crillon hotel after being placed under formal investigation for alleged organized crime on Telegram. read more
French authorities have refused to grant Telegram founder Pavel Durov permission to travel to the United States for meetings with potential investors, citing a lack of justification for the trip.
The Paris prosecutor's office said the decision was made on May 12, stating that Durov's request to travel 'did not appear imperative or justified', as reported by POLITICO. The denial comes amid ongoing legal proceedings against the tech entrepreneur.
Durov, a dual citizen of France and the United Arab Emirates, has been under judicial supervision in France since his arrest at a French airport in August 2024. He was formally indicted in September on six charges linked to illegal activity conducted via Telegram, the encrypted messaging platform he operates.
STORY CONTINUES BELOW THIS AD
Durov must seek official approval for any international travel as part of his bail conditions. He was previously authorised to visit Dubai between March 15 and April 7.
His legal team in France did not immediately respond to media queries, and his U.S. spokesperson has also remained silent on the matter.
Durov's relationship with French authorities has grown increasingly strained in recent months. On the day of Romania's presidential election runoff, he accused the French government — including Nicolas Lerner, head of the country's foreign intelligence service — of pressuring him to silence conservative voices on Telegram ahead of the vote. French officials swiftly and strongly rejected the accusation.
The Telegram founder's restricted mobility and deepening clash with Paris come at a time when his platform faces mounting scrutiny over its role in facilitating unmoderated content and encrypted communications.
The arrest of Durov last year ignited a debate about free speech online. Musk, who criticized the arrest of Durov, is also being probed by French prosecutors over alleged algorithmic bias on X.
Musk has used X to personally support right-wing parties and causes in countries including Germany and Britain, leading to concerns about undue foreign interference.
STORY CONTINUES BELOW THIS AD
Earlier this month, OpenMinds, a tech company focused on countering authoritarian influence, said it found that 24% of Romanian-language Telegram channels were spreading what it called Kremlin-backed disinformation.
Telegram said at the time users receive only the content they explicitly subscribe to.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Hindustan Times

8 minutes ago

• Hindustan Times

‘Trump pushed US into another war': Putin aide calls strikes on Iran nuclear sites a failure

Former Russian President Dmitry Medvedev has launched a scathing attack on the United States over its airstrikes on Iranian nuclear sites, alleging that the strikes failed to inflict any meaningful damage on Iran's nuclear infrastructure. Russian Security Council Deputy Chairman Dmitry Medvedev criticised U.S. strikes on Iran, claiming they caused little damage to its nuclear infrastructure.(AP File) He claimed the attacks have instead strengthened the Iranian regime and drawn Washington deeper into a broader Middle East conflict. Follow live updates on the Iran-Israel conflict here In a series of posts on X, Medvedev listed the consequences of the US strikes on Iran's nuclear sites. He said some countries might now be willing to give Iran nuclear weapons. 'Critical infrastructure of the nuclear fuel cycle appears to have been unaffected or sustained only minor damage. The enrichment of nuclear material — and, now we can say it outright, the future production of nuclear weapons — will continue. A number of countries are ready to directly supply Iran with their own nuclear warheads,' wrote Dmitry Medvedev. 'Israel is under attack, explosions are rocking the country, and people are panicking. The US is now entangled in a new conflict, with prospects of a ground operation looming on the horizon,' he added. Read: Bombers flew undetected for 18 hours: How US launched airstrikes on Iran's nuclear sites He criticised Donald Trump for dragging the US into another war, said global opinion is largely against the US and Israel, and mocked Trump's chances of ever winning a Nobel Peace Prize. 'Even stronger now': Medvedev says US strikes failed to weaken Iran regime 'Iran's political regime has survived — and in all likelihood, has come out even stronger. The people are rallying around the country's spiritual leadership, including those who were previously indifferent or opposed to it. Donald Trump, once hailed as 'president of peace,' has now pushed the US into another war,' said Medvedev. Read more: How US military's decoy B-2 Bomber mission helped it achieve stealth before Iran strikes 'The vast majority of countries around the world oppose the actions of Israel and the United States. At this rate, Trump can forget about the Nobel Peace Prize — not even with how rigged it has become. What a way to kick things off, Mr. President. Congratulations!' Dmitry Medvedev mentioned.

New Indian Express

13 minutes ago

• New Indian Express

‘We plan to add 1,700 beds by FY27; 57% beds likely in tier 2/3 cities'

Kochi- and Dubai-based Aster DM Healthcare, founded by Dr Azad Moopen in 1987 with a single clinic in Dubai, expects to complete the takeover of the Blackstone and TPG-backed Quality Care Hospital by the fourth quarter of this fiscal. The takeover will result in the third largest hospital chain Aster Quality Care, after Apollo and Fortis, with 38 hospitals across four brands -- Aster DM, Care Hospitals, KIMS Health and Evercare -- offering over 10,150 beds spread across 27 locations. Aster Quality Care is now jointly controlled by the Moopen family holding 24% and Blackstone owning 30.7%. In an interaction with Benn Kochuveedan of TNIE, Dr Azad Moopen shares his plans and expectations from the largest deal that his group has done. Excerpts: When do you see the merger of Quality Care Hospital getting completed? What are the targets in terms of revenue, profit expansion etc? The merger brings together four leading healthcare brands — Aster DM, Care Hospitals, KIMS Health, and Evercare — forming one of the largest hospital chains with 38 hospitals and over 10,150 beds across 27 cities. Financially, the merger strengthens the balance sheet and cash flow, enabling accelerated expansion plans. We aim to increase bed capacity to around 13,300 beds by FY27, further expanding our reach into tier 2 and 3 cities, providing a platform for sustained growth in the future. The merger is expected to be concluded by Q4FY26, with benefits expected to start flowing in from early FY27. What are the synergies you see from the merger? The merger unlocks significant synergies that will drive growth, operational efficiencies, and enhanced patient care across the combined network. Integrating our extensive hospital portfolios will allow the new entity to benefit from economies of scale by negotiating better terms with suppliers, reducing costs, and streamlining inventory management that will lower operational expenses and improve margins. What is the capex plan for fiscal 2026, especially in light of the merger-driven expansion? How many more hospitals and beds to come up this fiscal? We plan to add 1,700 beds by FY27, taking the total bed tally in India to over 6,800 through the organic route and will further look for expansion through the inorganic route. Our overall capital allocation for expansion across the domestic market is Rs 1,400 crore, of which we have already spent around Rs 350-400 crore. You have announced a Rs 850-crore investment in Kerala. What is the strategic thinking behind focusing so much on Kerala, which is often seen as a relatively mature market? Kerala is now poised for a significant transformation with a planned investment of Rs 850 crore over the next three years. This expansion will be anchored by two major greenfield projects: Aster Capital Trivandrum, a 454-bed tertiary care facility, and Aster MIMS Kasaragod, a 264-bed multispecialty hospital. In addition, our flagship hospital, Aster Medcity in Kochi, is undergoing a substantial upgrade. By FY27, our total bed capacity in Kerala is expected to reach 3,453, marking a milestone in our journey of delivering quality healthcare and driving sustainable growth. Affordable healthcare remains a chimera for the average citizen. What is Aster doing differently on this front? To balance affordability and sustainability, we centralise complex procedures in larger hospitals, while smaller units focus on primary/secondary care. By FY27, as much as 57% of our planned bed additions will be in tier 2/3 cities, reinforcing our commitment to these regions. Technology is key to bridging gaps, with telemedicine set to grow at 20.7% annually till FY30, reaching $15.1 billion. Our digital health arm is expanding tele-ICU, teleradiology, AI-driven diagnostics, IoT monitoring, and EMR platforms to enhance accessibility, affordability, and quality care nationwide. What are the digital initiatives of the group? Some of our technology-driven, patient-friendly initiatives include the introduction of the Aster Health app that offers appointment bookings, e-pharmacy, and access to digital health records. We have come up with AI-powered diagnostic solutions, including the Carpal Tunnel Syndrome detection tool in collaboration with the Indian Institute of Science. We are also expanding the home healthcare services under Aster@Home, providing in-home consultations, diagnostics, and physiotherapy, catering to India's growing elderly and chronic care populations.

The Hindu

15 minutes ago

• The Hindu

INS Tamal, India's last imported warship, to be commissioned on July 1

The Indian Navy is all set to commission its latest stealth multi-role frigate INS Tamal on July 1 at Kaliningrad in Russia. This will be the last warship of Indian Navy to have been built outside India and the eighth in the series of Krivak class frigates inducted from Russia over the past two decades. The ceremony will be presided over by Western Naval Commander Vice Admiral Sanjay J. Singh in the presence of several high-ranking Indian and Russian government and defence officials. INS Tamal has been built at Yantar Shipyard in Kaliningrad, Russia, and is the last warship to be inducted from a foreign source, in line with the Government of India's impetus on 'Atmanirbhar Bharat' and 'Make in India' initiatives. India, as part of the broader contract for Tushil class, is also building two similar frigates called the Triput class at Goa Shipyard Limited with transfer of technology and design assistance from the Russian side. By the conclusion of this series of ships, Indian Navy will be operating 10ships with similar capabilities and commonality in equipment, weapon and sensor fit over four different classes. The ship has 26 percent indigenous components, including the BrahMos long range cruise missile for targeting both at sea and land. The vessel has significant upgrades in its arsenal in comparison to its predecessors. The crew, comprising of over 250 personnel have undergone rigorous ashore as well as afloat training in extremely challenging winter conditions of St. Petersburg and Kaliningrad in Russia. INS Tamal has successively completed extensive sea trials undertaken over three months, proving its systems, weapons and sensors. The 125m long, 3900-ton warship, packs a lethal punch as it features an impressive blend of Indian and Russian cutting-edge technologies and best practices in warship construction. The ship's new design provides it with enhanced stealth features and greater stability characteristics. The number of Made-in-India systems have more than doubled to 33. Upon commissioning, INS Tamal will join the 'Sword Arm' of the Indian Navy, the Western Fleet, under the Western Naval Command.